SEC Comment Letter 0000000000-23-008596 to Haoxi Health Technology Ltd (HAO)
Haoxi Health Technology Ltd
Date: Aug. 8, 2023 · CIK: 0001954594 · Accession: 0000000000-23-008596
AI Filing Summary & Sentiment
Show Raw Text
United States securities and exchange commission logo
August 8, 2023
Zhen Fan
Chief Executive Officer
Haoxi Health Technology Ltd
Room 801, Tower C, Floor 8
Building 103
Huizhongli, Chaoyang District
Beijing, China
Re:Haoxi Health Technology Ltd
Amendment No. 3 to Draft Registration Statement on Form F-1
Submitted July 28, 2023
CIK No. 0001954594
Dear Zhen Fan:
We have reviewed your amended draft registration statement and have the following
comments. In some of our comments, we may ask you to provide us with information so we
may better understand your disclosure.
Please respond to this letter by providing the requested information and either submitting
an amended draft registration statement or publicly filing your registration statement on
EDGAR. If you do not believe our comments apply to your facts and circumstances or do not
believe an amendment is appropriate, please tell us why in your response.
After reviewing the information you provide in response to these comments and your
amended draft registration statement or filed registration statement, we may have additional
comments.
Amendment No. 3 to Draft Registration Statement on Form F-1 Submitted July 28, 2023
Cover Page
1.We note your response to comment 1 and reissue. You disclose in your registration
statement that none of your subsidiaries have made, and you do not anticipate any, cash
dividends to be paid in the foreseeable future. However, you also disclose on pages 5 and
29 that you "rely to a significant extent on dividends and other distributions on equity paid
by our Haoxi Beijing" to fund the Company. Please clarify your disclosure to explain the
inconsistency of how you have not received, and have no plans to receive, any dividends
from your subsidiaries, while you also rely on these dividends to fund your enterprise.
FirstName LastNameZhen Fan
Comapany NameHaoxi Health Technology Ltd
August 8, 2023 Page 2
FirstName LastName
Zhen Fan
Haoxi Health Technology Ltd
August 8, 2023
Page 2
Management's Discussion and Analysis of Financial Condition and Results of Operations
Results of Operations
For Six Months Ended December 31, 2021 and 2022
Revenue, page 68
2.We note your revised disclosures in response to comment 2 that added the change in the
number of customers. It is not clear how this contributes to the increase in the average
revenue per advertiser for the interim and annual periods. Please explain. Also, disclose
as appropriate the extent the increase in the average revenue per advertiser for these
periods relative to the corresponding prior year periods is attributable to the impact of
changes in price or volume/amount of services sold, introduction of new services or other
factors. If a factor is the mix of clients for which prices vary due to the nature of clients
served and/or services provided, disclose this and its extent, and describe how prices vary
by the nature of clients served and services provided. Further, clarify how your stated
relationship with Ocean Engine and ByteDance impacted your average revenue per
advertiser.
3.We note your response to comment 3. However, it is not clear why you have a decrease
in the number of customers from 242 at June 30, 2022 to 183 at December 31, 2023 when
you disclose on pages 10, 43 and 67 more people have opted to use various online services
since the beginning of the COVID-19 pandemic. Please clarify this in your disclosure and
disclose the reason for the decrease between these points in time. Additionally, explain to
us why the number of customers at June 30, 2022 is not comparable to the number of
customers at December 31, 2022 as stated in your response. You also state in your
response the decline in average revenue per customer during the six months ended
December 31, 2022 compared to that for each of the preceding annual periods is mainly
due to lower average customer expenditure during the second half 2022, as the economy
slowed down during the pandemic. It appears you should disclose this, and in doing so
clarify the time period represented by "during the pandemic" as it appears all of your
reported periods have been impacted by COVID-19.
You may contact Robert Shapiro at 202-551-3273 or Doug Jones at 202-551-3309 if you
have questions regarding comments on the financial statements and related matters. Please
contact Nicholas Nalbantian at 202-551-7470 or Erin Jaskot at 202-551-3442 with any other
questions.
Sincerely,
Division of Corporation Finance
Office of Trade & Services
cc: Ying Li